Stay updated on Gantenerumab in Early Alzheimer's Disease Clinical Trial
Sign up to get notified when there's something new on the Gantenerumab in Early Alzheimer's Disease Clinical Trial page.

Latest updates to the Gantenerumab in Early Alzheimer's Disease Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedMinor backend/UI update from v3.4.1 to v3.4.2 with no changes to study data or core content. The page presentation and information remain the same for users. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedWebsite version updated from v3.4.0 to v3.4.1; no user-facing content changes detected.SummaryDifference0.0%

- Check27 days agoChange DetectedShow glossary is now displayed by default, and the page includes updated QC and policy labels: 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. The release has been updated to version 3.4.0, replacing 3.3.4.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 with no changes to core content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedExpanded the Locations section with numerous new study sites across the US, Canada, Australia, Europe, and other regions, and removed several previous location blocks.SummaryDifference2%

- Check91 days agoChange DetectedThe page now includes a note that PubMed-derived publications are automatically filled and may not relate to the study, and the revision tag was updated to v3.3.2, while the old PubMed-derived publications wording and the v3.2.0 revision note were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Gantenerumab in Early Alzheimer's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Early Alzheimer's Disease Clinical Trial page.